Why Screen Adults for Cholesterol?
The U.S. Preventive Services Task Force (USPSTF) found good evidence that lipid measurement can identify asymptomatic middle-aged people at increased risk for coronary heart disease and good evidence that lipid-lowering drug therapy substantially decreases the incidence of coronary heart disease in such people with abnormal lipids and causes few major harms. The USPSTF concludes that the benefits of screening for and treating lipid disorders in middle-aged and older people substantially outweigh harms. The USPSTF recommends that clinicians routinely screen younger adults (men ages 20 to 35 and women ages 20 to 45) for lipid disorders if they have other risk factors for coronary heart disease.
U.S. Preventive Services Task Force, 2008